Recent advances in the design, development and therapeutic targets of chrysin derivatives.
The natural flavonoid chrysin exhibits broad-spectrum bioactivity. However, its clinical utility is severely constrained by suboptimal potency and unfavorable pharmacokinetic properties. Rational chemical modifications, including site-specific derivatization, molecular hybridization, and metal complexation, have yielde...